DK2939665T3 - Farmaceutisk sammensætning til behandling af hiv-infektioner - Google Patents

Farmaceutisk sammensætning til behandling af hiv-infektioner Download PDF

Info

Publication number
DK2939665T3
DK2939665T3 DK13867546.7T DK13867546T DK2939665T3 DK 2939665 T3 DK2939665 T3 DK 2939665T3 DK 13867546 T DK13867546 T DK 13867546T DK 2939665 T3 DK2939665 T3 DK 2939665T3
Authority
DK
Denmark
Prior art keywords
treatment
pharmaceutical composition
hiv infections
hiv
infections
Prior art date
Application number
DK13867546.7T
Other languages
English (en)
Inventor
Vikram Singkh Puniya
Gennady Andreevich Batyunin
Natalya Yurievna Malykh
Original Assignee
Otkrytoe Aktsionernoe Obschestvo Farmasyntez
Vikram Singkh Puniya
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=49957619&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK2939665(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Otkrytoe Aktsionernoe Obschestvo Farmasyntez, Vikram Singkh Puniya filed Critical Otkrytoe Aktsionernoe Obschestvo Farmasyntez
Application granted granted Critical
Publication of DK2939665T3 publication Critical patent/DK2939665T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
DK13867546.7T 2012-12-29 2013-09-19 Farmaceutisk sammensætning til behandling af hiv-infektioner DK2939665T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
RU2012158141/15A RU2505286C1 (ru) 2012-12-29 2012-12-29 Фармацевтическая композиция для лечения вич-инфекции, способ ее получения и способ лечения
PCT/RU2013/000817 WO2014104929A1 (ru) 2012-12-29 2013-09-19 Фармацевтическая композиция для лечения вич-инфекции

Publications (1)

Publication Number Publication Date
DK2939665T3 true DK2939665T3 (da) 2019-06-11

Family

ID=49957619

Family Applications (1)

Application Number Title Priority Date Filing Date
DK13867546.7T DK2939665T3 (da) 2012-12-29 2013-09-19 Farmaceutisk sammensætning til behandling af hiv-infektioner

Country Status (18)

Country Link
US (1) US10493034B2 (da)
EP (1) EP2939665B1 (da)
CN (1) CN104884050A (da)
CA (1) CA2896710C (da)
CY (1) CY1121660T1 (da)
DK (1) DK2939665T3 (da)
EA (1) EA029586B1 (da)
ES (1) ES2729568T3 (da)
HR (1) HRP20190882T1 (da)
HU (1) HUE043694T2 (da)
LT (1) LT2939665T (da)
PL (1) PL2939665T3 (da)
PT (1) PT2939665T (da)
RS (1) RS58837B1 (da)
RU (1) RU2505286C1 (da)
SI (1) SI2939665T1 (da)
TR (1) TR201908007T4 (da)
WO (1) WO2014104929A1 (da)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105194687A (zh) * 2015-10-22 2015-12-30 浙江医药高等专科学校 沙喹那韦或其甲磺酸盐的环糊精包合物制备方法
WO2017086835A1 (ru) * 2015-11-17 2017-05-26 Общество С Ограниченной Ответственностью "Валента-Интеллект" Фармацевтическая композиция, обладающая терапевтическим эффектом в отношении демиелинизирующих заболеваний (варианты)
RU2616267C1 (ru) * 2016-01-25 2017-04-13 Закрытое Акционерное Общество "БИОКОМ" Твердая лекарственная форма индинавира немедленного высвобождения и способ ее получения

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5484926A (en) * 1993-10-07 1996-01-16 Agouron Pharmaceuticals, Inc. HIV protease inhibitors
US8025899B2 (en) 2003-08-28 2011-09-27 Abbott Laboratories Solid pharmaceutical dosage form
US20050048112A1 (en) * 2003-08-28 2005-03-03 Jorg Breitenbach Solid pharmaceutical dosage form
CA2660374A1 (en) * 2006-08-10 2008-02-14 Cipla Limited Antiretroviral solid oral composition
PA8809601A1 (es) * 2007-12-24 2009-07-23 Cipla Ltd Combinación anti-retroviral
MX2010007645A (es) * 2008-01-11 2010-11-05 Cipla Ltd Forma de dosis farmaceutica solida.
WO2010006050A1 (en) * 2008-07-09 2010-01-14 Purdue Research Foundation Hiv protease inhibitors and methods for using
EP2279728A1 (en) * 2009-07-31 2011-02-02 Ranbaxy Laboratories Limited Solid dosage forms of HIV protease inhibitors
WO2012164575A2 (en) * 2011-05-27 2012-12-06 Hetero Research Foundation Amorphous ritonavir co-precipitated
WO2013106433A1 (en) * 2012-01-09 2013-07-18 Virginia Tech Intellectual Properties, Inc. Cellulose derivatives for inhibiting crystallization of poorly water-soluble drugs
WO2013128467A1 (en) * 2012-03-01 2013-09-06 Hetero Research Foundation Ritonavir compositions
WO2014184553A1 (en) * 2013-05-15 2014-11-20 Cipla Limited Pharmaceutical antiretroviral compositions

Also Published As

Publication number Publication date
PL2939665T3 (pl) 2020-01-31
LT2939665T (lt) 2019-07-25
CA2896710C (en) 2019-03-26
CY1121660T1 (el) 2020-07-31
ES2729568T3 (es) 2019-11-04
HRP20190882T1 (hr) 2019-09-20
CA2896710A1 (en) 2014-07-03
US20150297526A1 (en) 2015-10-22
CN104884050A (zh) 2015-09-02
RU2505286C1 (ru) 2014-01-27
EP2939665A4 (en) 2016-06-01
TR201908007T4 (tr) 2019-06-21
SI2939665T1 (sl) 2019-08-30
EP2939665A1 (en) 2015-11-04
EP2939665B1 (en) 2019-03-20
RS58837B1 (sr) 2019-07-31
HUE043694T2 (hu) 2019-09-30
PT2939665T (pt) 2019-06-14
US10493034B2 (en) 2019-12-03
WO2014104929A1 (ru) 2014-07-03
EA201500710A1 (ru) 2015-10-30
EA029586B1 (ru) 2018-04-30

Similar Documents

Publication Publication Date Title
DK2914248T4 (da) Farmaceutiske sammensætninger til behandlingen af cftr medierede sygdomme
DK2818482T3 (da) Farmaceutisk sammensætning til behandling af cancer
DK2824114T3 (da) Farmaceutisk sammensætning til behandling af cancer
DK2958900T3 (da) 2-aminopyrimidinderivater til behandling af virusinfektioner
DK3590928T3 (da) Pyrimidinderivater til behandling af virusinfektioner
DK3068392T3 (da) Fremgangsmåde til fremstilling af farmaceutiske sammensætninger til behandlingen af cftr-medierede sygdomme
DK3030262T3 (da) Kombineret farmaceutisk sammensætning
DK3520805T3 (da) Sammensætninger til behandling af myelofibrose
DK3181128T3 (da) Farmaceutisk nilotinib-sammensætning
DK2968221T3 (da) Farmaceutisk sammensætning af s-ketaminhydrochlorid
DK2852391T3 (da) Systemer til behandling af lungeinfektioner
DK2922526T3 (da) Fremstilling af semiplastiske farmaceutiske doseringsenheder
DK2694038T3 (da) Farmaceutisk sammensætning
DK3156056T3 (da) Farmaceutiske sammensætninger der består af sorbitanestere
DK3116491T3 (da) Farmaceutiske sammensætninger af terapeutisk aktive forbindelser
FR2997014B1 (fr) Composition sterile dermo-injectable
DK3378862T3 (da) Dihydropyrimidinoisoquinolinoner og farmaceutiske sammensætninger deraf til behandlingen af multipel sklerose
DK2903967T3 (da) Acylaminopyrimidinderivater til behandling af virusinfektioner og yderligere sygdomme
DK3106150T3 (da) Forbedrede farmaceutiske sammensætninger af pimobendan
DK2773648T3 (da) Farmaceutiske forbindelser til anvendelse i behandlingen af clostridium difficile-infektion
DK2872497T4 (da) Chromanyl-derivater til behandling af mitokondriel sygdom
BR112014029176A2 (pt) formulações injetáveis de aprepitante
DK2897594T3 (da) Farmaceutisk sammensætning
DK2906580T3 (da) Behandling af amyotrofisk lateral sklerose
DK2925338T3 (da) Frysetørret formulering af tat-nr2b9c